Clinical Trials · NCT00294723
To Evaluate the Effect of Liraglutide Versus Glimepiride (Amaryl®) on Haemoglobin A1c
- Phase
- Phase 3
- Recruitment status
- Terminated
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 746
- Start date
- Feb 2006
- Locations
- 117 sites, 3 countries
- Primary endpoint
- Change in Glycosylated Haemoglobin A1c (HbA1c) at Week 52